NCT00893971View on ClinicalTrials.gov

Study to Evaluate Single Inhaled Doses of PT001, PT003, PT005 and PT001 Plus PT005 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

July 31, 2009

Study Completion Date

July 31, 2009

Conditions
Healthy Volunteers
Interventions
DRUG

PT001

Inhaled PT001, single dose

DRUG

PT005

Inhaled PT005, single dose

DRUG

PT003

Inhaled PT003, single dose

DRUG

PT001 + PT005

Inhaled PT001 + PT005, single dose

Trial Locations (1)

4006

Dr Joanne Marjason, Herston

Sponsors
All Listed Sponsors
lead

Pearl Therapeutics, Inc.

INDUSTRY